Literature DB >> 15185826

ReMeEx device (External Mechanical Regulator) for incontinence: implantation and regulation procedure, complications and results at 3 years follow-up.

Franco Mantovani1, Chiara Castelnuovo, Paolo Bernardini.   

Abstract

UNLABELLED: A new sling technique that allows a postoperative adjustment of the sling tension is presented with encouraging results in the treatment of female stress urinary incontinence. The readjustment prevents the need of a reoperation in case of relapse with great compliance of the patients. Indications for surgical treatment of female stress urinary incontinence by ReMeEx included patients with: fixed urethra, urethral hypermobility, intrinsic sphyncteric deficiency and previous incontinence surgical interventions. Out of 32 patients treated, 31 were cured with transitory urge in 2 and readjustment in 3. In one case the device was removed for infection. IN
CONCLUSION: the ReMeEx system offers the possibility to modify the sling support level whenever needed during patient's life. Wiyh the ReMeEx system we can and should improve the outcome of these patients leaving them completely dry, without any urine leakage.

Entities:  

Mesh:

Year:  2004        PMID: 15185826

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  3 in total

1.  Readjustable sling procedure for the treatment of female stress urinary incontinence with intrinsic sphincter deficiency: preliminary report.

Authors:  Dong Hoon Yoo; Joon Hwa Noh
Journal:  Korean J Urol       Date:  2010-06-21

2.  A modified Altis® mid-urethral sling that allows immediate post-operative adjustment: experience in 197 patients.

Authors:  Brett J Friedman; Jennifer Nguyen; Annah Vollstedt; Mireya Diaz; Ly Hoang Roberts; Larry T Sirls
Journal:  Int Urol Nephrol       Date:  2022-01-04       Impact factor: 2.370

3.  Assessing the Readjustable Sling Procedure (Remeex System) for Female Stress Urinary Incontinence With Detrusor Underactivity.

Authors:  Kwang Jin Ko; Yoon Seok Suh; Hyun Hwan Sung; Gyu Ha Ryu; Munjae Lee; Kyu-Sung Lee
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.